+91 9650760803 
Published: March 24, 2020 | Updated: August 6, 2026
Key Takeaways
- 01. Disease overview:
Rheumatoid arthritis is an autoimmune disorder in which the immune system attacks healthy joint tissues and sometimes other organs, leading to inflammation, pain, stiffness, and potential disability. - 02. Stem-cell therapy described:
Stem-cell therapy uses mesenchymal stem cells to reduce inflammation, modulate immune activity, support tissue repair, and improve joint function—offering an alternative to traditional drug-based treatments. - 03. Delivery methods listed:
The implantation methods mentioned include intravenous, intra-arterial, intramuscular, intrathecal, subcutaneous, and surgical administration of stem cells in the joint or body. - 04. Results & improvements:
Patients treated at the centre reported reduced joint inflammation, less pain, improved flexibility, and decreased swelling after therapy. - 05. Experimental status & caution:
Stem-cell therapy for rheumatoid arthritis remains experimental; outcomes vary among individuals, and no cure is guaranteed. The centre emphasises that results depend on patient condition and internal body state.
Overview
What Is Rheumatoid Arthritis?
Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the synovium — the lining of the joints — causing inflammation, pain, stiffness, and, over time, joint damage. Unlike osteoarthritis, which results from mechanical wear, RA is driven by immune dysfunction, and can also affect organs beyond the joints, including the lungs, heart, eyes, and blood vessels.
RA typically affects joints symmetrically — both wrists, both hands, or both knees at once — which is one of the features doctors use to distinguish it from other forms of arthritis (see Diagnosis). Left untreated or poorly controlled, RA can progress to permanent joint deformity and disability, which is why early diagnosis and consistent management matter more than any single treatment choice.
Conventional RA management relies on disease-modifying antirheumatic drugs (DMARDs) and biologic therapies, which work well for many patients but not all — some continue to experience active disease despite treatment (“treatment-refractory” RA). It’s this group — patients whose disease remains active despite standard medication — for whom investigational approaches like stem cell therapy are most often being researched, not as a first-line alternative to medication.
If you’re researching this page because conventional treatment hasn’t controlled your RA adequately, the sections below explain what current stem cell research shows, who may be a reasonable candidate, and what a realistic outcome looks like. For readers still building a general understanding of RA and its treatment options, our Orthopedic Conditions hub covers related joint and autoimmune conditions we address, including Osteoarthritis, Systemic Lupus, and Ankylosing Spondylitis — all autoimmune or inflammatory joint conditions with related, but distinct, mechanisms.
As a dedicated stem cell clinic for rheumatoid arthritis in Delhi, our specialist team also serves as a regenerative medicine center for rheumatoid arthritis in India, coordinating rheumatological evaluation, cell processing, and follow-up care under one accredited facility.
What Causes Rheumatoid Arthritis?
Rheumatoid arthritis is an autoimmune disorder — its exact trigger isn’t fully understood, but research points to a combination of factors that raise risk rather than a single identifiable cause:
- Genetic predisposition — certain genes (notably HLA-DR4 and related variants) are associated with higher RA risk, though carrying these genes does not mean RA will develop.
- Environmental triggers — smoking is the most consistently identified environmental risk factor; certain bacterial and viral infections have also been studied as potential triggers in genetically susceptible individuals.
- Immune system dysregulation — the disease process itself involves the immune system producing antibodies (such as rheumatoid factor and anti-CCP antibodies) that target the body’s own joint tissue.
- Hormonal factors — RA occurs roughly 2–3 times more often in women than men, and hormonal factors are thought to play a role, though the exact mechanism isn’t fully established.
- Age — RA can occur at any age but most commonly begins between 30 and 60.
Why identifying the driver matters for treatment choice
RA management differs meaningfully depending on disease stage and how a patient has responded to prior treatment. Patients newly diagnosed with mild disease are typically managed with standard DMARDs first. Investigational approaches such as stem cell therapy are more relevant for patients with moderate-to-severe, treatment-refractory disease — see Treatment below for how Viezec’s specialist team assesses candidacy.
Related reading: How Stem Cell Therapy Works for the general mechanism, or jump to Diagnosis for the specific tests used to confirm RA and assess disease activity.
Symptoms of Rheumatoid Arthritis
RA typically affects joints on both sides of the body symmetrically — a distinguishing feature from many other forms of arthritis. Commonly affected joints include the wrists, fingers, knees, ankles, and feet.
Joint symptoms:
- Pain, swelling, and warmth in affected joints
- Morning stiffness lasting more than 30 minutes, or stiffness after periods of rest
- Reduced range of motion, and in advanced or poorly-controlled disease, visible joint deformity over time
Systemic (whole-body) symptoms:
- Fatigue and general low energy
- Low-grade fever
- Chest pain when breathing deeply (can indicate pleurisy — inflammation around the lungs)
- Dry eyes and mouth (can indicate secondary Sjögren’s syndrome)
- Eye redness, burning, or discharge
- Numbness, tingling, or a burning sensation in the hands and feet
- Sleep disturbance
What to do if you notice these signs
Symptom pattern alone cannot confirm RA — it needs to be distinguished from other inflammatory and autoimmune conditions through specific testing. See Diagnosis below for the exact blood and imaging tests used. If you’re already diagnosed with RA and are researching this page because symptoms persist despite medication, that’s the specific situation covered under Treatment.
How Is Rheumatoid Arthritis Diagnosed?
RA can be difficult to diagnose early because its initial symptoms overlap with several other conditions. Diagnosis combines a physical examination with laboratory and imaging tests:
| Test | What it checks | Why it matters |
|---|---|---|
| Rheumatoid Factor (RF) | Antibodies associated with RA | Present in a majority of RA patients, though not exclusive to RA |
| Anti-CCP antibody test | Cyclic citrullinated peptide antibodies | More specific to RA than RF; useful for early diagnosis and prognosis |
| ESR (Erythrocyte Sedimentation Rate) & CRP (C-Reactive Protein) | General inflammation markers | Track disease activity, not RA-specific but useful for monitoring |
| X-rays | Joint damage progression | Establishes baseline and tracks structural change over time |
| MRI / Ultrasound | Soft tissue and early synovial inflammation | Detects inflammation before it’s visible on X-ray |
Your treating specialist will typically request recent Rheumatoid Factor, X-ray, and ESR results as a starting point for evaluation — if you have these from the last 3–6 months, you can upload them for a free case review rather than repeating tests.
Note on interpreting your own results: A positive RF or anti-CCP test alone doesn’t confirm active disease requiring investigational treatment — disease activity, joint involvement, and response to prior medication are assessed together. This is explained further under Who Is a Candidate in the Treatment section.
Stem Cell Treatment for Rheumatoid Arthritis
Stem cell therapy for rheumatoid arthritis uses mesenchymal stem cells (MSCs), most often sourced from bone marrow or adipose (fat) tissue, for their studied immunomodulatory and anti-inflammatory properties. It is delivered by Viezec’s specialist team — recognized among patients researching a reliable stem cell hospital for rheumatoid arthritis in Delhi — at our accredited New Delhi facility as a supportive, investigational option primarily considered for patients with moderate-to-severe RA who have not responded adequately to conventional DMARD or biologic therapy.
How does it work?
Mesenchymal stem cells are being researched in RA for several specific mechanisms:
- Immune modulation — MSCs are studied for their ability to influence T-cell activity and reduce the autoimmune response that drives joint tissue damage, rather than suppressing the immune system broadly.
- Anti-inflammatory signalling — MSCs release paracrine (cell-signalling) factors researchers believe can reduce local synovial inflammation.
- Supporting T-regulatory cell activity — some research points to MSCs promoting regulatory immune cells that help the body limit self-directed immune attacks, rather than replacing damaged cartilage directly.
It’s worth being precise about what this therapy is not claimed to do: current evidence does not support stem cell therapy regenerating destroyed cartilage or reversing structural joint damage that has already occurred. The research focus is on modulating the underlying immune-driven inflammation, not tissue regrowth.
Who is a candidate?
You may be considered a candidate if you have:
- A confirmed RA diagnosis (positive RF/anti-CCP, consistent clinical presentation)
- Moderate-to-severe disease activity despite an adequate trial of conventional DMARDs or biologics
- No active infection or other contraindication identified during specialist evaluation
- Patients across India and internationally researching a stem cell provider for rheumatoid arthritis often reach out at this stage — our specialist team reviews your RF/anti-CCP results and treatment history before confirming candidacy.
You are not likely to be a candidate if you have newly diagnosed, mild RA that hasn’t yet been trialed on standard first-line medication — conventional treatment remains the appropriate starting point in that scenario, and our specialists will advise this directly.
Delivery methods
Depending on your specific case, cells may be administered via:
- Intravenous (IV) infusion
- Intra-articular (directly into the affected joint)
- Subcutaneous injection
- Intramuscular injection
- Intra-arterial or intrathecal delivery, in select cases
See our dedicated page on stem cell delivery methods for how each route is selected based on diagnosis.
What to expect: the treatment process
- Consultation and diagnostic review — your RF, anti-CCP, ESR/CRP, and imaging reports are reviewed by our specialist team.
- Cell sourcing — bone marrow or adipose tissue collection under local anaesthesia.
- Lab processing — cells are isolated and prepared under certified laboratory conditions.
- Administration — via the delivery method selected for your case.
- Follow-up monitoring — inflammation markers and joint assessment tracked over subsequent months (see Improvements).
For international patients, see our visa and travel support and plan-your-visit resources.
Stem Cell Implantation Methods for Rheumatoid Arthritis
At Viezec’s New Delhi facility, the implantation route is selected based on disease distribution and severity, not applied uniformly to every patient. The methods used include:
- Intravenous administration — for systemic immunomodulatory effect
- Intra-articular injection — directly into significantly affected joints
- Subcutaneous injection
- Intramuscular injection
- Intra-arterial delivery — in select cases requiring targeted regional effect
- Intrathecal delivery — used only where neurological involvement is being separately assessed
- Surgical administration — reserved for specific structural cases, determined jointly with an orthopedic specialist
Each method carries a different risk-benefit profile, and the choice is made by your treating specialist based on joint involvement, disease activity, and overall health — not standardized across all patients. Read more on our Stem Cell Delivery Methods page.
Frequently Asked Questions
What is stem cell treatment for rheumatoid arthritis?
Stem cell treatment involves using regenerative cells to reduce inflammation, repair damaged joint tissues, and potentially improve mobility and reduce pain in patients with rheumatoid arthritis.
Who is eligible for stem cell therapy?
Candidates typically include adults with moderate to severe rheumatoid arthritis who have not responded well to conventional treatments. Eligibility is determined after a thorough medical evaluation.
How is the therapy administered?
Stem cells are usually injected directly into affected joints or delivered intravenously. The procedure is minimally invasive and performed under medical supervision in a clinical setting.
Is stem cell therapy safe for rheumatoid arthritis patients?
When performed in certified clinics by experienced professionals, stem cell therapy is generally safe. Some patients may experience mild side effects like temporary swelling, pain at the injection site, or fatigue.
How long does it take to see results?
Patients may notice improvements in pain, joint stiffness, and mobility within a few weeks, but optimal results can take several months depending on disease severity and individual response.
How many sessions are required?
The number of sessions depends on the severity of arthritis and patient goals. Most patients undergo 1–3 sessions with follow-ups to assess progress and adjust treatment as needed.
Can stem cell therapy replace medications?
Stem cell therapy is generally considered a complementary treatment. It may reduce reliance on medications, but most patients continue some form of conventional therapy alongside stem cell treatment.
Which is the best stem cell center for rheumatoid arthritis treatment in Delhi, India?
Viezec operates as a regenerative medicine center for rheumatoid arthritis in Delhi, India, offering physician-supervised, evidence-based treatment programs for patients with moderate-to-severe, treatment-refractory disease. As a recognized stem cell provider for rheumatoid arthritis in India, Viezec coordinates diagnostic review, cell processing, and structured follow-up through NABH/NABL-accredited facilities, rather than offering a one-time, unsupervised procedure.
For more questions, visit our FAQs page or request an evaluation with our expert team.
How Much Does Stem Cell Therapy Cost for Rheumatoid Arthritis?
The cost of regenerative medicine treatment for rheumatoid arthritis in India depends on several factors — including the stage of the disease, affected joints, type and quantity of stem cells used, the number of therapy sessions, and the expertise of the medical center. Treatment prices vary widely across countries due to differences in healthcare systems, technologies, and labor costs. Below is a global cost comparison to help patients plan their treatment budget effectively.
Cost Comparison: Select Countries
The following table presents approximate cost ranges for a complete stem cell therapy program for rheumatoid arthritis, covering consultation, stem cell harvesting and processing, injection procedures, and medical supervision.
| Country | Average Cost (in USD) | Average Cost (in INR) |
|---|---|---|
| United States 🇺🇸 | $18,000 – $30,000 | ₹14,90,000 – ₹24,80,000 |
| United Kingdom 🇬🇧 | $14,000 – $25,000 | ₹11,60,000 – ₹20,60,000 |
| Germany 🇩🇪 | $16,000 – $28,000 | ₹13,20,000 – ₹23,10,000 |
| Singapore 🇸🇬 | $12,000 – $20,000 | ₹9,90,000 – ₹16,50,000 |
While advanced nations such as the USA, UK, and Germany offer cutting-edge technologies, their treatment costs are significantly higher due to healthcare and operational expenses. In contrast, India provides world-class regenerative treatments at a fraction of the cost, making it one of the most sought-after destinations for medical travelers seeking stem cell therapy for rheumatoid arthritis.
The affordability in India comes from lower operating costs and favorable currency rates rather than a compromise on treatment quality. Leading hospitals in India employ internationally trained specialists, GMP-certified labs, and globally recognized stem cell protocols to ensure safe, ethical, and effective care.
Why Choose Viezec?
Viezec collaborates with accredited hospitals and expert rheumatologists offering cutting-edge regenerative therapies. Our mission is to ensure transparent pricing, ethical medical practices, and customized treatment planning for every patient’s unique condition.
Get a Personalized Cost Estimate
Every patient’s case is different. Connect with our medical consultants today to receive a personalized quotation and a detailed treatment plan for your rheumatoid arthritis condition.
Testimonials
Arvind K. – Delhi, India – February 2020 – ⭐⭐⭐⭐☆
“Rheumatoid arthritis made even small tasks painful. After Viezec’s stem cell therapy, my joint stiffness reduced, and I can work more easily.”
Laura W. – Manchester, UK – July 2020 – ⭐⭐⭐⭐⭐
“I suffered from constant swelling in my hands. Post-treatment at Viezec, the pain decreased, and I can now cook and write without trouble.”
Ahmed S. – Cairo, Egypt – December 2020 – ⭐⭐⭐⭐☆
“RA flare-ups were ruining my quality of life. After therapy at Viezec, my joint inflammation reduced, and my mobility improved.”
Isabella F. – Rome, Italy – March 2021 – ⭐⭐⭐⭐⭐
“My knees were badly affected by RA. Viezec’s stem cell treatment brought relief, and I can now enjoy light exercise again.”
George L. – Athens, Greece – September 2021 – ⭐⭐⭐⭐☆
“I relied on painkillers for years. After stem cell therapy at Viezec, my dependence reduced, and my energy levels improved.”
Hannah P. – Toronto, Canada – February 2022 – ⭐⭐⭐⭐⭐
“My joints were swollen and painful every morning. Post-treatment at Viezec, the stiffness has eased, and I feel active again.”
Omar N. – Amman, Jordan – August 2022 – ⭐⭐⭐⭐☆
“RA had made daily movement difficult. Viezec’s stem cell therapy improved my flexibility, and I’m able to walk longer distances now.”
Maria S. – Madrid, Spain – April 2023 – ⭐⭐⭐⭐⭐
“I had severe joint pain for years. After Viezec’s therapy, the swelling reduced, and I finally feel like living a normal life again.”
Daniel R. – Sydney, Australia – October 2023 – ⭐⭐⭐⭐☆
“My wrists and fingers were too stiff for work. Stem cell therapy at Viezec restored my mobility, and I can type and write again.”
Fatima H. – Istanbul, Turkey – June 2025 – ⭐⭐⭐⭐⭐
“Rheumatoid arthritis was stealing my independence. Thanks to Viezec’s treatment, my pain has reduced, and I feel stronger and happier.”
Improvements Seen After Stem Cell Therapy for Rheumatoid Arthritis
Research on stem cell therapy for RA reports measurable changes in inflammatory markers and joint symptoms in some patients with moderate-to-severe, treatment-refractory disease. It is not a cure, and outcomes vary by disease stage, duration, and individual response.
What patients have reported
Based on outcomes tracked at our centre and consistent with published research findings:
- Reduction in joint inflammation — measured via ESR/CRP and clinical joint assessment
- Reduced pain levels — self-reported and tracked over follow-up visits
- Improved flexibility and range of motion
- Decreased visible joint swelling
How improvement is monitored, not just reported
| Marker | What it shows | Typically checked at |
|---|---|---|
| ESR / CRP (blood test) | Inflammation trend | Baseline, 1, 3, 6 months |
| Joint swelling/tenderness count | Clinical disease activity | Baseline, 3 months |
| Patient-reported pain score | Symptom trend | Baseline, monthly |
| Range of motion assessment | Functional improvement | Baseline, 3 months |
What the research does not yet show
Most published evidence to date comes from systematic reviews of smaller clinical trials and case series rather than large multi-center randomized trials, and researchers consistently call for larger studies to confirm long-term efficacy and standardize treatment protocols. Stem cell therapy for RA is not established as a treatment that reverses existing joint damage, and it does not replace conventional DMARD or biologic therapy where those remain effective. Your treating specialist will confirm, based on your specific disease activity markers, whether measurable improvement is a realistic goal in your case.
Quick FAQ
Does stem cell therapy cure rheumatoid arthritis?
No. It is researched as a way to potentially reduce inflammation and disease activity; it does not reverse existing joint damage or guarantee remission.
How soon are improvements typically checked?
Most protocols recheck inflammation markers and joint assessment at 1, 3, and 6 months post-treatment.
Does this replace RA medication?
No — it’s considered alongside, not instead of, conventional DMARD/biologic treatment in most cases.
Mechanism of Action in Rheumatoid Arthritis
Mesenchymal stem cells are being studied for how they interact with the immune system in RA, rather than for replacing damaged joint tissue directly. Current research points to three areas of mechanism:
- Paracrine signalling — MSCs release cytokines and growth factors that are believed to modulate local inflammatory activity in and around affected joints.
- T-cell modulation — research suggests MSCs can influence T-cell behavior, potentially reducing the autoimmune activity that drives RA’s joint-tissue attack.
- Promotion of regulatory immune cells — some studies point to MSCs supporting T-regulatory cell populations, which help the immune system distinguish healthy tissue from perceived threats.
This is an active, evolving area of immunology research rather than a fully established mechanism — see Scientific References for the specific studies this is based on. For a general explanation of how mesenchymal stem cells behave across conditions, see our Stem Cell Healing Potential page.
Our Promise
Viezec is committed to transparent, evidence-based regenerative medicine care for rheumatoid arthritis patients — not overstated promises. In practice, this means:
- No cure claims. Stem cell therapy is offered as a researched, investigational option for treatment-refractory RA — never marketed as a guaranteed cure.
- Rheumatological evaluation before treatment. No protocol is proposed without a completed review of your RF/anti-CCP status, inflammation markers, and treatment history.
- Named, credentialed medical oversight. Every treatment plan is reviewed by a qualified specialist.
- Regulatory transparency. Our protocols operate within India’s ICMR guidelines for investigational stem cell use, and we disclose which framework applies to your specific treatment, directly and in writing.
- Accredited facilities. Our treatment and cell-processing facilities hold NABH accreditation and NABL accreditation.
- Written, itemized cost estimates provided after medical evaluation, before any commitment.
- Location and access clarity. Our facility is based in New Delhi, India, with dedicated support for international patients including visa assistance and remote follow-up.
- Honest evidence communication. Where evidence is still developing, we say so directly and cite specific supporting studies — see Scientific References — rather than implying stronger proof than currently exists.
- Recognized regenerative medicine provider. Viezec is known among patients evaluating a regenerative medicine treatment provider for rheumatoid arthritis in Delhi and across India for our transparent, evidence-first approach to investigational care.
Treatment Results of Rheumatoid Arthritis at Viezec
Stem cell therapy for rheumatoid arthritis at Viezec is used to support disease management in moderate-to-severe, treatment-refractory cases — with a focus on reducing inflammation and improving joint function. It is not a cure; results vary by disease duration, severity, and individual response, and are evaluated case-by-case.
What does current research show?
- A 2021 review (Gowhari Shabgah et al., Stem Cell Research & Therapy) found mesenchymal stem cell-based approaches show potential to modulate immune activity relevant to RA, while noting that clinical translation remains an active area of study.
- A 2020 clinical applications update (Lopez-Santalla et al., Cells) reviewed the evidence base for MSC therapy in RA and highlighted both promising immunomodulatory findings and the need for larger controlled trials.
- A 2023 systematic review and meta-analysis (Mesa et al., PLOS ONE) evaluating safety and efficacy of MSC therapy in RA patients found a generally favorable safety profile across the studies reviewed.
- A 2023 review (Ochi et al., International Journal of Molecular Sciences) discusses both the possibilities and current challenges of mesenchymal stromal/stem cell-based approaches for RA management.
- A 2025 review (Wang et al., Stem Cell Research & Therapy) examines mechanisms, clinical applications, and microenvironmental interactions relevant to MSC-based RA therapy, reflecting continued active research interest.
What results can realistically be expected?
| Outcome measure | What research suggests |
|---|---|
| Inflammatory markers (ESR/CRP) | Improvement reported in some clinical studies |
| Joint pain and stiffness | Reduction reported in patient-level outcomes |
| Range of motion / mobility | Improvement reported in several patients |
| Disease remission | Not an established or guaranteed outcome |
| Safety | Generally favorable across studies reviewed to date, with continued monitoring recommended |
Is this a replacement for RA medication?
No. Stem cell therapy at Viezec is offered as a complementary, physician-supervised option for patients whose disease remains active despite conventional treatment — not as a substitute for DMARDs or biologics where those remain appropriate.
Watch patient outcome videos for further context on reported results.
Treatment Disclaimer
Is stem cell therapy a guaranteed cure for rheumatoid arthritis?
No. Stem cell therapy for RA is not a guaranteed cure, and no clinic — including Viezec — can promise remission or symptom reversal as an outcome. It is offered as a supportive, investigational option for patients with treatment-refractory disease, based on individual evaluation.
What does the current evidence show?
Research into MSC therapy for RA is still evolving. Some studies report improvements in inflammatory markers and joint symptoms in selected patients, while others show variable results. This is an active area of clinical research, not an established standard-of-care treatment recognized by major rheumatology bodies at this time.
Who is this treatment intended for?
Primarily patients with moderate-to-severe RA who have not responded adequately to conventional DMARD or biologic therapy, following rheumatological evaluation. It is not typically offered as a first-line treatment for newly diagnosed, mild RA.
What results can I realistically expect?
Individual results vary based on disease duration, severity, and prior treatment history. We do not publish blanket improvement percentages, because outcomes differ meaningfully between patients. Your specialist will discuss what’s realistic for your specific case.
Who oversees treatment decisions?
All treatment plans are reviewed by our named treating specialist team at our New Delhi facility, following rheumatological evaluation. No protocol is recommended without this review. We do not use embryonic or fetal cells in any treatment.
Where can I get a specific answer for my case?
Book a consultation with our specialist team to review your reports and discuss candidacy.
Scientific References
The following peer-reviewed studies, clinical trials, and scientific publications support current research on stem cell therapy for rheumatoid arthritis.
Conclusion
Stem cell therapy offers a transformative approach for individuals battling rheumatoid arthritis by targeting inflammation at the cellular level and promoting tissue regeneration. At Viezec, we combine advanced medical expertise with ethical standards to deliver safe and effective regenerative treatments tailored to each patient’s condition. Our mission is to help patients regain mobility, reduce chronic pain, and improve their overall quality of life through scientifically backed stem cell procedures. With India emerging as a global destination for affordable and high-quality healthcare, Viezec provides international patients with compassionate care and trusted medical guidance. Whether you’re comparing options for stem cell treatment for rheumatoid arthritis in Delhi or exploring a regenerative medicine hospital for rheumatoid arthritis in India more broadly, Viezec’s specialist-led, accredited care pathway is designed to give every patient a clear, honest picture of what to expect.
Ethical & Transparent Patient Guidance
We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.
We Also Offer Treatments For
Our Testimonials
Related Videos
Recent Blog Posts
4.8 average based on 654 reviews.
